Mosanna Therapeutics
The company is developing a pharmaceutical nasal spray designed to treat obstructive sleep apnea by reactivating upper airway muscles during sleep. This medicinal approach aims to restore the body's natural airway control reflex as an alternative to mechanical devices. The product is intended for patients seeking a nighttime treatment that integrates into a standard bedtime routine.
Visit websiteBasel, Switzerland
Healthtech
Pharmaceuticals
Biotechnology
Funding summary
- Total raised
- €70.0M
- Funding rounds
- 2
Investors in Mosanna Therapeutics
Investors on record for Mosanna Therapeutics. Click any investor to view their CAPLINK profile and funding criteria.
Fundraising for a startup like Mosanna Therapeutics?
Explore CAPLINK's investor database of thousands of active VCs and angels.
Browse investors